Pharmacosmos announces the first results of the PHOSPHARE study program in which iron isomaltoside was compared directly to ferric carboxymaltose in two identical randomized controlled trials. Iron isomaltoside 1000 and ferric carboxymaltose are intravenous iron preparations that can be administered in high doses to
More
Results of a study comparing the incidence of hypophosphatemia after high dose
[wp_ad_camp_4]Dextran-supplier Pharmacosmos extends its quality dextran offerings with DEAE-Dextran, manufactured in the
Pharmacosmos announces the first results of the PHOSPHARE study program in which iron isomaltoside was compared directly to ferric carboxymaltose
MoreResults of a study comparing the incidence of hypophosphatemia after high dose IV iron substitution have been presented at the
More[wp_ad_camp_4]Dextran-supplier Pharmacosmos extends its quality dextran offerings with DEAE-Dextran, manufactured in the company’s FDA and EDQM-approved facility in Denmark. Holbæk,
More
